86 related articles for article (PubMed ID: 1698964)
1. Red blood cells bearing CD4 bind to gp120 covered plates and aggregate with cells expressing gp120.
Arvinte T; Schulz B; Madoulet C; Nicolau C
J Acquir Immune Defic Syndr (1988); 1990; 3(11):1041-5. PubMed ID: 1698964
[TBL] [Abstract][Full Text] [Related]
2. Recombinant CD4-selected human immunodeficiency virus type 1 variants with reduced gp120 affinity for CD4 and increased cell fusion capacity.
McKeating J; Balfe P; Clapham P; Weiss RA
J Virol; 1991 Sep; 65(9):4777-85. PubMed ID: 1870202
[TBL] [Abstract][Full Text] [Related]
3. CD4 peptide-protein conjugates, but not recombinant human CD4, bind to recombinant gp120 from the human immunodeficiency virus in the presence of serum from AIDS patients.
Ghetie V; Slaughter C; Wheeler HT; Uhr JW; Vitetta ES
Proc Natl Acad Sci U S A; 1991 Jul; 88(13):5690-3. PubMed ID: 2062847
[TBL] [Abstract][Full Text] [Related]
4. Full-length CD4 electroinserted in the erythrocyte membrane as a long-lived inhibitor of infection by human immunodeficiency virus.
Zeira M; Tosi PF; Mouneimne Y; Lazarte J; Sneed L; Volsky DJ; Nicolau C
Proc Natl Acad Sci U S A; 1991 May; 88(10):4409-13. PubMed ID: 2034680
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human CD4 elicits antibody responses different in epitope specificity from those that cellular CD4 elicits.
Reeves JP; Epstein SL
Mol Immunol; 1993 Jun; 30(8):765-73. PubMed ID: 7684821
[TBL] [Abstract][Full Text] [Related]
6. Heparin specifically inhibits binding of V3 loop antibodies to HIV-1 gp120, an effect potentiated by CD4 binding.
Harrop HA; Coombe DR; Rider CC
AIDS; 1994 Feb; 8(2):183-92. PubMed ID: 8043225
[TBL] [Abstract][Full Text] [Related]
7. Deamidation of soluble CD4 at asparagine-52 results in reduced binding capacity for the HIV-1 envelope glycoprotein gp120.
Teshima G; Porter J; Yim K; Ling V; Guzzetta A
Biochemistry; 1991 Apr; 30(16):3916-22. PubMed ID: 2018763
[TBL] [Abstract][Full Text] [Related]
8. Trypsin-resistant gp120 receptors are upregulated on short-term cultured human epidermal Langerhans cells.
Dezutter-Dambuyant C; Schmitt DA; Dusserre N; Hanau D; Kolbe HV; Kieny MP; Gazzolo L; Macé K; Pasquali JL; Olivier R
Res Virol; 1991; 142(2-3):129-38. PubMed ID: 1896637
[TBL] [Abstract][Full Text] [Related]
9. T-cell membrane-associated serine protease, tryptase TL2, binds human immunodeficiency virus type 1 gp120 and cleaves the third-variable-domain loop of gp120. Neutralizing antibodies of human immunodeficiency virus type 1 inhibit cleavage of gp120.
Niwa Y; Yano M; Futaki S; Okumura Y; Kido H
Eur J Biochem; 1996 Apr; 237(1):64-70. PubMed ID: 8620895
[TBL] [Abstract][Full Text] [Related]
10. Internal-image anti-idiotype HIV-1gp120 antibody in human immunodeficiency virus 1 (HIV-1)-seropositive individuals with thrombocytopenia.
Karpatkin S; Nardi MA; Kouri YH
Proc Natl Acad Sci U S A; 1992 Feb; 89(4):1487-91. PubMed ID: 1741404
[TBL] [Abstract][Full Text] [Related]
11. Characterization of recombinant gp120 and gp160 from HIV-1: binding to monoclonal antibodies and soluble CD4.
Moore JP; McKeating JA; Jones IM; Stephens PE; Clements G; Thomson S; Weiss RA
AIDS; 1990 Apr; 4(4):307-15. PubMed ID: 2190605
[TBL] [Abstract][Full Text] [Related]
12. Amino acid residues of the human immunodeficiency virus type I gp120 critical for the binding of rat and human neutralizing antibodies that block the gp120-sCD4 interaction.
McKeating JA; Thali M; Furman C; Karwowska S; Gorny MK; Cordell J; Zolla-Pazner S; Sodroski J; Weiss RA
Virology; 1992 Sep; 190(1):134-42. PubMed ID: 1382339
[TBL] [Abstract][Full Text] [Related]
13. Characterization of in vitro inhibition of human immunodeficiency virus by purified recombinant CD4.
Byrn RA; Sekigawa I; Chamow SM; Johnson JS; Gregory TJ; Capon DJ; Groopman JE
J Virol; 1989 Oct; 63(10):4370-5. PubMed ID: 2550671
[TBL] [Abstract][Full Text] [Related]
14. Range of CD4-Bound Conformations of HIV-1 gp120, as Defined Using Conditional CD4-Induced Antibodies.
Kaplan G; Roitburd-Berman A; Lewis GK; Gershoni JM
J Virol; 2016 May; 90(9):4481-4493. PubMed ID: 26889042
[TBL] [Abstract][Full Text] [Related]
15. Development and characterization of a whole-cell radioligand binding assay for [125I]gp120 of HIV-1.
To LP; Balasubramanian V; Charlton ME; Francis TA; Doyle C; Sweetnam PM
J Immunoassay; 1992; 13(1):61-83. PubMed ID: 1569213
[TBL] [Abstract][Full Text] [Related]
16. Rat monoclonal antibodies to nonoverlapping epitopes of human immunodeficiency virus type 1 gp120 block CD4 binding in vitro.
Cordell J; Moore JP; Dean CJ; Klasse PJ; Weiss RA; McKeating JA
Virology; 1991 Nov; 185(1):72-9. PubMed ID: 1718090
[TBL] [Abstract][Full Text] [Related]
17. CD4 binding site antibodies inhibit human immunodeficiency virus gp120 envelope glycoprotein interaction with CCR5.
Raja A; Venturi M; Kwong P; Sodroski J
J Virol; 2003 Jan; 77(1):713-8. PubMed ID: 12477875
[TBL] [Abstract][Full Text] [Related]
18. Binding to CD4 of synthetic peptides patterned on the principal neutralizing domain of the HIV-1 envelope protein.
Autiero M; Abrescia P; Dettin M; Di Bello C; Guardiola J
Virology; 1991 Dec; 185(2):820-8. PubMed ID: 1720590
[TBL] [Abstract][Full Text] [Related]
19. Neuronal injury due to HIV-1 envelope protein is blocked by anti-gp120 antibodies but not by anti-CD4 antibodies.
Kaiser PK; Offermann JT; Lipton SA
Neurology; 1990 Nov; 40(11):1757-61. PubMed ID: 2234433
[TBL] [Abstract][Full Text] [Related]
20. HIV-infected cells are killed by rCD4-ricin A chain.
Till MA; Ghetie V; Gregory T; Patzer EJ; Porter JP; Uhr JW; Capon DJ; Vitetta ES
Science; 1988 Nov; 242(4882):1166-8. PubMed ID: 2847316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
